24-羟化在维生素D代谢稳态调节中的关键作用
该交叉临床试验纳入11例维生素D缺乏且其他健康的社区参与者,补充维生素D3后25(OH)D平均升高2.7倍、24,25(OH)2D平均升高4.3倍,而PTH、FGF-23和1,25(OH)2D均值无变化。数学模型提示24-羟化酶活性在25(OH)D≥50 ng/mL时最大、在25(OH)D<10-20 ng/mL时受抑约90%,1,25(OH)2D/24,25(OH)2D比值较总25(OH)D更好地预测模型化24-羟化酶活性。
要点
- 维生素D3补充后25(OH)D平均升高2.7倍、24,25(OH)2D平均升高4.3倍,PTH、FGF-23和1,25(OH)2D均值无变化。
- 模型提示25(OH)D≥50 ng/mL时24-羟化酶活性最大,25(OH)D<10-20 ng/mL时受抑约90%。
- 1,25(OH)2D/24,25(OH)2D比值与模型化24-羟化酶活性的相关性(ρ=-0.85;P=.001)优于总25(OH)D(ρ=0.51;P=.01)。
核心结论
- 抑制24-羟化酶通过降低1,25(OH)2D代谢清除,构成对抗症状性维生素D缺乏的第一道防线。
- 1,25(OH)2D/24,25(OH)2D比值纳入24,25(OH)2D水平,可反映24-羟化酶活性,是评估维生素D状态的有用指标。
- 当维生素D可利用性受限时,24-羟化酶活性受抑,24,25(OH)2D水平降低、1,25(OH)2D/24,25(OH)2D比值升高,该比值升高标志稳态调节在维生素D缺乏早期即被触发。
研究设计与样本
- 交叉临床试验,研究社区参与者在维生素D3补充前后的变化。
- 纳入11例维生素D缺乏(25(OH)D≤20 ng/mL)且其他健康的个体。
- 维生素D3补充方案为50000 IU每周一次或两次(取决于体重指数),持续4-6周,以使25(OH)D达到30 ng/mL或以上。
主要发现
- 维生素D3补充使平均25(OH)D升高2.7倍、24,25(OH)2D升高4.3倍。
- 补充后PTH、成纤维细胞生长因子-23和1,25(OH)2D的平均水平无变化。
- 数学模型提示24-羟化酶活性在25(OH)D≥50 ng/mL时最大,在25(OH)D<10-20 ng/mL时达到最低(约90%抑制)。
- 1,25(OH)2D/24,25(OH)2D比值预测模型化24-羟化酶活性(h)的ρ=-0.85(P=.001),优于总血浆25(OH)D的ρ=0.51(P=.01)和24,25(OH)2D/25(OH)D比值的ρ=0.37(P=.3)。
关键数值与推荐
- 维生素D缺乏定义为25(OH)D≤20 ng/mL。
- 补充目标为25(OH)D≥30 ng/mL。
- 24-羟化酶活性最大见于25(OH)D≥50 ng/mL,最低(约90%抑制)见于25(OH)D<10-20 ng/mL。
- 1,25(OH)2D/24,25(OH)2D比值与模型化24-羟化酶活性的相关系数ρ=-0.85(P=.001)。
临床怎么用
- 作者认为1,25(OH)2D/24,25(OH)2D比值可作为维生素D状态的有用指标,因其纳入24,25(OH)2D水平并反映24-羟化酶活性。
- 作者指出该比值升高标志稳态调节被触发,发生于维生素D缺乏早期阶段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The body has evolved homeostatic mechanisms to maintain free levels of Ca+2 and 1,25-dihydroxyvitamin D (1,25(OH)2D) within narrow physiological ranges. Clinical guidelines emphasize important contributions of parathyroid hormone (PTH) in maintaining this homeostasis. OBJECTIVE: This work aimed to investigate mechanisms of homeostatic regulation of vitamin D (VitD) metabolism and to apply mechanistic insights to improve clinical assessment of VitD status. METHODS: This crossover clinical trial studied community participants before and after VitD3 supplementation. Participants included 11 otherwise healthy individuals with VitD deficiency (25-hydroxyvitamin D [25(OH)D] ≤20 ng/mL). VitD3 supplements (50 000 IU once or twice a week depending on body mass index, for 4-6 weeks) were administered to achieve 25(OH)D of 30 ng/mL or greater. RESULTS: VitD3 supplementation significantly increased mean 25(OH)D by 2.7-fold and 24,25-dihydroxyvitamin D (24,25(OH)2D) by 4.3-fold. In contrast, mean levels of PTH, fibroblast growth factor-23, and 1,25(OH)2D did not change. Mathematical modeling suggested that 24-hydroxylase activity was maximal for 25(OH)D 50 ng/mL or greater and achieved a minimum (∼90% suppression) with 25(OH)D less than 10 to 20 ng/mL. The 1,25(OH)2D/24,25(OH)2D ratio better predicted modeled 24-hydroxylase activity (h) (ρ = -0.85; P = .001) compared to total plasma 25(OH)D (ρ = 0.51; P = .01) and the 24,25(OH)2D/25(OH)D ratio (ρ = 0.37; P = .3). CONCLUSION: Suppression of 24-hydroxylase provides a first line of defense against symptomatic VitD deficiency by decreasing metabolic clearance of 1,25(OH)2D. The 1,25(OH)2D/24,25(OH)2D ratio provides a useful index of VitD status since it incorporates 24,25(OH)2D levels, and therefore provides insight into 24-hydroxylase activity. When VitD availability is limited, this suppresses 24-hydroxylase activity-thereby decreasing the level of 24,25(OH)2D and increasing the 1,25(OH)2D/24,25(OH)2D ratio. Thus, an increased 1,25(OH)2D/24,25(OH)2D ratio signifies triggering of homeostatic regulation, which occurs at early stages of VitD deficiency.
引用
- Shahidzadeh Yazdi Z, Streeten EA, Whitlatch HB, et al. Critical Role for 24-Hydroxylation in Homeostatic Regulation of Vitamin D Metabolism. J Clin Endocrinol Metab. 2025. PMID: 38481375. doi:10.1210/clinem/dgae156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。